chr3-47123852-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014159.7(SETD2):​c.784A>G​(p.Ser262Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,398,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S262R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

SETD2
NM_014159.7 missense

Scores

18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.53

Publications

0 publications found
Variant links:
Genes affected
SETD2 (HGNC:18420): (SET domain containing 2, histone lysine methyltransferase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
SETD2 Gene-Disease associations (from GenCC):
  • Luscan-Lumish syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • Rabin-Pappas syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome
    Inheritance: AD Classification: STRONG Submitted by: ClinGen, PanelApp Australia
  • Sotos syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intellectual developmental disorder, autosomal dominant 70
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07138839).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014159.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SETD2
NM_014159.7
MANE Select
c.784A>Gp.Ser262Gly
missense
Exon 3 of 21NP_054878.5
SETD2
NM_001349370.3
c.652A>Gp.Ser218Gly
missense
Exon 2 of 20NP_001336299.1A0A1W2PPX9
SETD2
NR_146158.3
n.973A>G
non_coding_transcript_exon
Exon 3 of 22

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SETD2
ENST00000409792.4
TSL:5 MANE Select
c.784A>Gp.Ser262Gly
missense
Exon 3 of 21ENSP00000386759.3Q9BYW2-1
SETD2
ENST00000330022.11
TSL:1
n.397A>G
non_coding_transcript_exon
Exon 1 of 19ENSP00000332415.7H7BXT4
SETD2
ENST00000952253.1
c.784A>Gp.Ser262Gly
missense
Exon 3 of 20ENSP00000622312.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.15e-7
AC:
1
AN:
1398174
Hom.:
0
Cov.:
32
AF XY:
0.00000145
AC XY:
1
AN XY:
689578
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31534
American (AMR)
AF:
0.00
AC:
0
AN:
35618
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25150
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35726
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79172
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
9.28e-7
AC:
1
AN:
1077838
Other (OTH)
AF:
0.00
AC:
0
AN:
58076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.039
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.050
T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.66
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.071
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.55
N
PhyloP100
1.5
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.39
N
REVEL
Benign
0.088
Sift
Benign
0.34
T
Sift4G
Benign
0.26
T
Polyphen
0.0010
B
Vest4
0.17
MutPred
0.13
Loss of glycosylation at T258 (P = 0.0336)
MVP
0.42
MPC
0.24
ClinPred
0.046
T
GERP RS
3.8
Varity_R
0.041
gMVP
0.096
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs544730198; hg19: chr3-47165342; API